Results for:(61 found)
Jan 2, 2013 12:07PM on Top StocksBy TheStreet Staff

TheStreet's Adam Feuerstein gazes into his crystal ball to offer his biotechnology forecast for the new year.

Dec 27, 2012 11:51AM on Top StocksBy Minyanville.com

Biogen Idec, Pfizer, Bristol-Myers and Celgene are among companies awaiting US approval of key treatments.

Dec 27, 2012 9:03AM on Top StocksBy Stock Traders Daily

The market is growing and the opportunities are there, but so are the risks.

Dec 13, 2012 1:12PM on Top StocksBy InvestorPlace

Some pharma stocks could get a shot in the arm as CDC issues early warning.

Oct 31, 2012 12:10PM on Top StocksBy TheStreet Staff

The second-generation HIV drug is being developed to counteract expiring patents.

Oct 31, 2012 10:38AM on Top StocksBy InvestorPlace

The revenue in question seems too small to make a difference.

Sep 19, 2012 11:01AM on Top StocksBy MSN Money Partner

GlaxoSmithKline is downgraded to 'underperform,' while AstraZeneca is upgraded to 'neutral.'

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More